EMEA Says Caution Should Be Exercised With Reductil Prescriptions

There is nothing new in this warning from the European Medicines Agency

The European Medicines Agency has issued advice to doctors that the weight loss medication Reductil should be only prescribed ‘with caution’. This statement was put out following concern that the Sibutramine Cardiovascular Outcome Trial (SCOUT), which looked at over 10,000 men and women observed a higher incidence of heart attacks and strokes among those using Reductil.

In fact we have already written about this at Ukmedix News and it is important that everyone realises that if they have heart problems or high blood pressure they should stay well away from the use of Reductil. There is nothing new in this warning from the European Medicines Agency because even the labeling on the Reductil weight loss drug warns that it shouldn’t be used by these people.

In the UK the Medicines and Healthcare Products Regulatory Agency which records any adverse reactions to medications say that there have been around 2,000 reported cases. At the same time it is estimated that there have been over 2 million prescriptions issued. Dr David Haslam from the National Obesity Forum stressed the importance of Reductil being prescribed to the right people and that it should never be given to those with a history of heart problems.

An important point which every overweight and obese individual should be aware of is that their weight condition is a far more dangerous to their blood pressure, their hearts and the likelihood of having a stroke than the Reductil weight loss drug. Obesity is the second largest preventable cause of death after smoking in the western world and millions of these deaths are caused by heart failure and other conditions related to poor circulation. Being overweight should be considered to be a life threatening illness.

Reductil functions by suppressing the hormone serotonin which regulates appetite and thus makes you feel full up quicker. The weight loss drug Reductil is the only legal appetite suppressant available on the market in the UK today.